Epigenetic regulation of synapsin genes in mood disorders

Neuropsychopharmacology

Volumn 38, Issue 1, 2013, Pages 239-241

  Cruceanu, Cristiana ^a   Freemantle, Erika ^a   Alda, Martin ^b   Rouleau, Guy A ^c   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; HISTONE H3; LITHIUM; MESSENGER RNA; MOOD STABILIZER; SYNAPSIN; SYNAPSIN I; SYNAPSIN II; SYNAPSIN III; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AUTISM; BIPOLAR DISORDER; BRAIN REGION; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA METHYLATION; EPILEPSY; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NOTE; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHIZOPHRENIA; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; TRANSCRIPTION INITIATION SITE; TREATMENT RESPONSE;

ANIMALS; BRAIN; EPIGENESIS, GENETIC; HUMANS; MOOD DISORDERS; SYNAPSINS;

EID: 84869078168     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.186     Document Type: Note

References (9)

1. Cesca F, Baldelli P, Valtorta F, Benfenati F (2010). The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 91: 313-348.
2. Cruceanu C, Alda M, Grof P, Rouleau GA, Turecki G (2012). Synapsin II is involved in the molecular pathway of lithium treatment in bipolar disorder. PloS one 7: e32680.
3. Cruceanu C, Alda M, Nagy C, Freemantle E, Rouleau GA, Turecki G (2012). H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression. Int J Neuropsychopharmacol 9: 1-11.
4. D'Addario C, Dell'Osso B, Palazzo MC, Benatti B, Lietti L, Cattaneo E et al (2012). Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 37: 1647-1655.
5. Jiang Y, Langley B, Lubin FD, Renthal W, Wood MA, Yasui DH et al (2008). Epigenetics in the nervous system. J Neurosci 28: 11753-11759.
6. Lopez JP, Mamdani F, Labonte B, Beaulieu MM, Yang JP, Berlim MT et al (2012). Epigenetic regulation of BDNF expression according to antidepressant response. Mol psychiatry; doi:10.1038/mp.2012.38.
7. Miklem G, Hillier L (2012). UCSC CpG islands track (unpublished) based on Gardiner-Garden M. and Frommer M. CpG islands in vertebrate genomes. J Mol Biol 196: 261-282.
8. Murphy BC, O'Reilly RL, Singh SM (2008). DNA methylation and mRNA expression of SYN III, a candidate gene for schizophrenia. BMC Med Genet 9: 115.
9. Pieribone VA, Porton B, Rendon B, Feng J, Greengard P, Kao HT (2002). Expression of synapsin III in nerve terminals and neurogenic regions of the adult brain. J Comp Neurol 454: 105-114.